TRDA ▼ -0.8% - Entrada Therapeutics, Inc. $TRDA - Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study 18-NOV-2026 03:00 AM ET